NOXXON PHARMA NV (ALNOX.PA) Stock Income Statement
EPA:ALNOX - Euronext Paris - Matif - NL0012044762 - Common Stock - Currency: EUR
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | 1.00K | 1.00K | 0.00 | 4.00K | N/A | |||
| Operating Expenses | 13.46M | 5.82M | 4.07M | 4.62M | 4.73M | |||
| Research and Development | 10.66M | 4.02M | 2.11M | 2.21M | 2.39M | |||
| Selling, General, and Administrative Expenses | 2.88M | 1.88M | 2.12M | 2.49M | 2.57M | |||
| Operating Income | -13.46M | -5.82M | -4.07M | -4.62M | -4.73M | |||
| Interest Income/Expense | -1.28M | -4.92M | 70.00K | -6.42M | -660.00K | |||
| Other Income/Expense | 270.00K | 290.00K | 3.02M | N/A | N/A | |||
| Non Recurring Items | 10.00K | 40.00K | 120.00K | 300.00K | 0.00 | |||
| Income Before Taxes | -14.45M | -10.41M | -860.00K | -10.74M | -5.39M | |||
| Income Tax | 1.00K | 0.00 | 1.00K | 1.00K | 1.00K | |||
| Net Income | -14.45M | -10.40M | -860.00K | -10.73M | -5.39M | |||
| EBITDA | -13.39M | -5.76M | -4.02M | -4.60M | -4.70M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.22 | -0.32 | -0.08 | -2.70 | -2.54 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in EUR